Literature DB >> 20496178

Translational research in NeuroAIDS: a neuroimmune pharmacology-related course.

Amanda Brown1, Bruce Shiramizu, Avindra Nath, Valerie Wojna.   

Abstract

Neuroimmune pharmacology (NIP) can be considered a multidisciplinary science where areas of neuroscience, immunology, and pharmacology intersect in neurological disorders. The R25 training program titled "Translational Research in NeuroAIDS and Mental Health (TR-NAMH): An innovative mentoring program to promote diversity in NeuroAIDS Research (R25 MH080661)" at the Johns Hopkins University is a web-based interactive course with the goal to improve the capacity of high quality research by developing mentoring programs for (1) doctoral and postdoctoral candidates and junior faculty from racial and ethnic minorities and (2) non-minority individuals at the same levels, whose research focuses on NeuroAIDS disparity issues such as HIV-associated neurocognitive disorders (HAND). This web-based interactive course overcomes the limitations of traditional education such as access to expert faculty and financial burden of scientists from racial and ethnic minority groups in the field of NeuroAIDS research and NIP and identifies rich nurturing environments for investigators to support their careers. The TR-NAMH program identifies a cadre of talented students and investigators eager to commit to innovative educational and training sessions in NeuroAIDS and NIP. The interplay between NIP changes precipitated by HIV infection in the brain makes the study of HAND an outstanding way to integrate important concepts from these two fields. The course includes activities besides those related to didactic learning such as research training and long-term mentoring; hence, the newly learned topics in NIP are continually reinforced and implemented in real-time experiences. We describe how NIP is integrated in the TR-NAMH program in the context of HAND.

Entities:  

Mesh:

Year:  2010        PMID: 20496178      PMCID: PMC3155799          DOI: 10.1007/s11481-010-9222-y

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  33 in total

1.  Frequency of apolipoprotein E4 among older compared with younger HIV patients: support for detrimental effect of E4 on survival.

Authors:  Victor Valcour; Bruce Shiramizu; Cecilia Shikuma
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-08       Impact factor: 11.205

2.  Characteristics of Activated Monocyte Phenotype Support R5-Tropic Human Immunodeficiency Virus.

Authors:  Sody M Munsaka; Melissa Agsalda; David Troelstrup; Ningjie Hu; Qigui Yu; Bruce Shiramizu
Journal:  Immunol Immunogenet Insights       Date:  2009

Review 3.  Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.

Authors:  Richard J Noel; Vanessa Rivera-Amill; Shilpa Buch; Anil Kumar
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

4.  Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders.

Authors:  Bruce Shiramizu; Andrew E Williams; Cecilia Shikuma; Victor Valcour
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

5.  Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment.

Authors:  Wojciech Rozek; Mary Ricardo-Dukelow; Sondra Holloway; Howard E Gendelman; Valerie Wojna; Loyda M Melendez; Pawel Ciborowski
Journal:  J Proteome Res       Date:  2007-10-12       Impact factor: 4.466

6.  Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women.

Authors:  Valerie Wojna; Lizbeth Robles; Richard L Skolasky; Raul Mayo; Ola Selnes; Tania de la Torre; Elizabeth Maldonado; Avindra Nath; Loyda M Meléndez; Jose Lasalde-Dominicci
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

7.  Building infrastructure for HIV/AIDS and mental health research at institutions serving minorities.

Authors:  Richard Yanagihara; Linda Chang; Thomas Ernst
Journal:  Am J Public Health       Date:  2009-02-26       Impact factor: 9.308

8.  Interaction of SIV/SHIV infection and morphine on plasma oxidant/antioxidant balance in macaque.

Authors:  Antonio Pérez-Casanova; Kazim Husain; Richard J Noel; Vanessa Rivera-Amill; Anil Kumar
Journal:  Mol Cell Biochem       Date:  2007-10-13       Impact factor: 3.396

9.  Proteomic analyses associate cystatin B with restricted HIV-1 replication in placental macrophages.

Authors:  C Luciano-Montalvo; P Ciborowski; F Duan; H E Gendelman; L M Meléndez
Journal:  Placenta       Date:  2008-10-31       Impact factor: 3.481

10.  Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment.

Authors:  Ixane Velázquez; Marinés Plaud; Valerie Wojna; Richard Skolasky; Juliana Pérez Laspiur; Loyda M Meléndez
Journal:  J Neuroimmunol       Date:  2008-12-19       Impact factor: 3.478

View more
  2 in total

1.  Enhancing diversity in the public health research workforce: the research and mentorship program for future HIV vaccine scientists.

Authors:  Carrie J Sopher; Blythe Jane S Adamson; Michele P Andrasik; Danna M Flood; Steven F Wakefield; David M Stoff; Ryan S Cook; James G Kublin; Jonathan D Fuchs
Journal:  Am J Public Health       Date:  2014-08-14       Impact factor: 9.308

Review 2.  Mentorship of Underrepresented Physicians and Trainees in Academic Medicine: a Systematic Review.

Authors:  Eliana Bonifacino; Eloho O Ufomata; Amy H Farkas; Rose Turner; Jennifer A Corbelli
Journal:  J Gen Intern Med       Date:  2021-02-02       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.